Nodality Lands $15,500,000 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    201 Gateway Blvd. South San Francisco, CA 94080
  • Company Description
    Nodality Inc. is a privately held emerging biotechnology company focused on developing mechanistic
    and patient-specific classification of disease.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    Proceeds from this financing will be used to support commercial activities associated with the company’s launch of its first test in acute myelogenous leukemia, as well as to advance ongoing and new research and development programs in other hematologic malignancies, autoimmune diseases, and solid tumors.
  • M&A Terms
  • Venture Investor
    Pfizer Strategic Investments Group
  • Venture Investor
    Kleiner Perkins Caufield & Byers
  • Venture Investor
    Maverick Capital
  • Venture Investor
    TPG Biotechnology Partners

Trending on Xconomy